Company / Net Income
NEUROONE MEDICAL TECHNOLOGIES Corp Net Income History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$12.3M
FY2025
5-year range
-$13.6M / -$9.9M
FY2021-FY2025
Trend
-3.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has declined for 3 consecutive years, from -$10M in FY2022 to -$12M in FY2025.
Based on SEC 10-K filings.
-$12M in FY2025.
Declined from -$10M to -$12M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- NEUROONE MEDICAL TECHNOLOGIES Corp's net income has declined for 3 consecutive years.
- In FY2025, net income decreased 3.9% year-over-year.
- Peak net income was recorded in FY2011.
- Lowest net income in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$12.3M | -3.9% |
| FY2024 | -$11.9M | -18.6% |
| FY2023 | -$10.0M | -0.5% |
| FY2022 | -$9.9M | +27.1% |
| FY2021 | -$13.6M | -21598.2% |
| FY2016 | -$62.9K | -73.4% |
| FY2015 | -$36.2K | -18.6% |
| FY2014 | -$30.6K | -10.7% |
| FY2012 | -$27.6K | -356.7% |
| FY2011 | -$6.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026